{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:54:08Z","timestamp":1780707248684,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:00:00Z","timestamp":1733529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:00:00Z","timestamp":1733529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03566-0","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T13:22:06Z","timestamp":1733577726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Elevated C-reactive protein levels and cardiovascular risk in prurigo nodularis patients with sleep disturbance: a multi-center cohort study"],"prefix":"10.1007","volume":"317","author":[{"given":"Emily Z.","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Parthasarathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Shahsavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davies","family":"Gage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yagiz","family":"Akiska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Callwood-Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Mysore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn G.","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,7]]},"reference":[{"key":"3566_CR1","doi-asserted-by":"publisher","unstructured":"Kwatra SG (2022) Prurigo Nodularis. JAMA Dermatol 158. https:\/\/doi.org\/10.1001\/jamadermatol.2021.5307","DOI":"10.1001\/jamadermatol.2021.5307"},{"key":"3566_CR2","doi-asserted-by":"publisher","unstructured":"Whang KA, Le TK, Khanna R et al (2022) Health-related quality of life and economic burden of prurigo nodularis. J Am Acad Dermatol 86. https:\/\/doi.org\/10.1016\/j.jaad.2021.05.036","DOI":"10.1016\/j.jaad.2021.05.036"},{"key":"3566_CR3","doi-asserted-by":"publisher","unstructured":"Aggarwal P, Choi J, Sutaria N et al (2021) Clinical characteristics and disease burden in prurigo nodularis. Clin Exp Dermatol 46. https:\/\/doi.org\/10.1111\/ced.14722","DOI":"10.1111\/ced.14722"},{"key":"3566_CR4","doi-asserted-by":"publisher","unstructured":"Sutaria N, Alphonse MP, Marani M et al (2022) Cluster analysis of circulating plasma biomarkers in Prurigo Nodularis reveals a distinct systemic inflammatory signature in African americans. J Invest Dermatology 142. https:\/\/doi.org\/10.1016\/j.jid.2021.10.011","DOI":"10.1016\/j.jid.2021.10.011"},{"key":"3566_CR5","doi-asserted-by":"publisher","unstructured":"Belzberg M, Alphonse MP, Brown I et al (2021) Prurigo Nodularis is characterized by systemic and cutaneous T helper 22 Immune polarization. J Invest Dermatology 141. https:\/\/doi.org\/10.1016\/j.jid.2021.02.749","DOI":"10.1016\/j.jid.2021.02.749"},{"key":"3566_CR6","doi-asserted-by":"publisher","unstructured":"Sutaria N, Marani M, Choi J et al (2022) Racial differences in dysregulation of the renin-angiotensin-aldosterone system in patients with prurigo nodularis. J Dermatol Sci 105. https:\/\/doi.org\/10.1016\/j.jdermsci.2022.02.004","DOI":"10.1016\/j.jdermsci.2022.02.004"},{"key":"3566_CR7","doi-asserted-by":"publisher","unstructured":"Larson VA, Tang O, Stander S, Miller LS, Kang S, Kwatra SG (2019) Association between prurigo nodularis and malignancy in middle-aged adults. J Am Acad Dermatol 81. https:\/\/doi.org\/10.1016\/j.jaad.2019.03.083","DOI":"10.1016\/j.jaad.2019.03.083"},{"key":"3566_CR8","doi-asserted-by":"publisher","unstructured":"Joel MZ, Hydol-Smith J, Kambala A, Cornman HL, Kwatra SG (2023) Prevalence and comorbidity burden of prurigo nodularis in United States adults enrolled in the all of us research program. J Am Acad Dermatol 89. https:\/\/doi.org\/10.1016\/j.jaad.2023.06.045","DOI":"10.1016\/j.jaad.2023.06.045"},{"key":"3566_CR9","doi-asserted-by":"publisher","unstructured":"Joel MZ, Taylor MT, Cornman HL, Kambala A, Reddy SV, Gabriel S, Kwatra SG (2023) Risk of incident sleep disorders in patients with prurigo nodularis: a population-level analysis using the Health Improvement Network. JAAD Int 13. https:\/\/doi.org\/10.1016\/j.jdin.2023.07.009","DOI":"10.1016\/j.jdin.2023.07.009"},{"key":"3566_CR10","doi-asserted-by":"publisher","unstructured":"Roh YS, Marani M, Choi U et al (2022) Validation of International classification of diseases Tenth Revision code for prurigo nodularis. J Am Acad Dermatol 87. https:\/\/doi.org\/10.1016\/j.jaad.2021.10.026","DOI":"10.1016\/j.jaad.2021.10.026"},{"key":"3566_CR11","unstructured":"Donnelly K (2006) SNOMED-CT: The advanced terminology and coding system for ehealth. In: Studies in Health Technology and Informatics"},{"key":"3566_CR12","unstructured":"Butler R (2007) The ICD-10 general equivalence mappings. J Am Health Inform Manage Association. 78"},{"key":"3566_CR13","doi-asserted-by":"publisher","unstructured":"Kaaz K, Szepietowski JC, Matusiak \u0141 (2019) Sleep quality among adult patients with chronic dermatoses. Postepy Dermatol Alergol 36. https:\/\/doi.org\/10.5114\/ada.2019.84007","DOI":"10.5114\/ada.2019.84007"},{"key":"3566_CR14","doi-asserted-by":"publisher","unstructured":"Patel SP, Khanna R, Choi J et al (2021) Sleep disturbance in adults with chronic pruritic dermatoses is associated with increased C-reactive protein levels. J Am Acad Dermatol 84. https:\/\/doi.org\/10.1016\/j.jaad.2020.08.059","DOI":"10.1016\/j.jaad.2020.08.059"},{"key":"3566_CR15","doi-asserted-by":"publisher","unstructured":"Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, Mullington JM (2004) Effect of sleep loss on C-Reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43. https:\/\/doi.org\/10.1016\/j.jacc.2003.07.050","DOI":"10.1016\/j.jacc.2003.07.050"},{"key":"3566_CR16","doi-asserted-by":"publisher","unstructured":"van Leeuwen WMA, Lehto M, Karisola P et al (2009) Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP. PLoS ONE 4. https:\/\/doi.org\/10.1371\/journal.pone.0004589","DOI":"10.1371\/journal.pone.0004589"},{"key":"3566_CR17","doi-asserted-by":"publisher","unstructured":"Feng Y, Ye D, Wang Z et al (2022) The role of Interleukin-6 Family members in Cardiovascular diseases. Front Cardiovasc Med 9. https:\/\/doi.org\/10.3389\/fcvm.2022.818890","DOI":"10.3389\/fcvm.2022.818890"},{"key":"3566_CR18","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/J.JAAD.2020.04.183","volume":"83","author":"AH Huang","year":"2020","unstructured":"Huang AH, Williams KA, Kwatra SG (2020) Prurigo nodularis: Epidemiology and clinical features. J Am Acad Dermatol 83:1559\u20131565. https:\/\/doi.org\/10.1016\/J.JAAD.2020.04.183","journal-title":"J Am Acad Dermatol"},{"key":"3566_CR19","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1056\/NEJMoa2301333","volume":"389","author":"SG Kwatra","year":"2023","unstructured":"Kwatra SG, Yosipovitch G, Legat FJ et al (2023) Phase 3 trial of Nemolizumab in patients with Prurigo Nodularis. N Engl J Med 389:1579\u20131589. https:\/\/doi.org\/10.1056\/NEJMoa2301333","journal-title":"N Engl J Med"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03566-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03566-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03566-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T02:02:14Z","timestamp":1733623334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03566-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,7]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3566"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03566-0","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,7]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB status"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}